AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchanges as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing related to the company's shareholding in dematerialized (demat) form. No specific financial numbers, corporate actions, or strategic updates were disclosed in this filing. The submission is typically filed periodically by the company or its Registrar and Share Transfer Agent to confirm compliance with depository-related norms.
This is a routine procedural filing with no material impact on the company's operations, financials, or stock price. Shareholders need not take any action on this disclosure.